Since June 2021, when registered nurse Danielle Baker received a coerced COVID-19 vaccine from her Ohio employer, she has battled not only transverse myelitis — a spinal cord inflammation diagnosis that left her permanently disabled — but also a relentless insurance system that repeatedly denied coverage for her sole effective treatment. Baker is one of thousands of Americans who suffered adverse effects from COVID-19 vaccines and found that their health insurance companies refused to cover the very therapies needed to recover, leaving them to pay out-of-pocket costs reaching $12,000 every three weeks for intravenous immunoglobulin therapy, according to interviews published this month by The Defender.
Patients across multiple states report identical obstacles when seeking treatment for vaccine injuries. Insurance companies reject therapies as experimental or medically unnecessary, refuse to cover specialized tests, and terminate treatments that stabilize conditions — even when physicians document clinical improvement.
Connecticut resident Kendall Smith received a dysautonomia panel costing $1,000 out-of-pocket after her Cigna-linked insurer, RxBenefits, refused coverage. Her neurologist warned her to expect initial denials, noting an 80% rejection rate for similar referrals across insurance carriers.
Erik Klint, a California video engineer who toured with rock bands before receiving the Johnson & Johnson booster in 2021, now uses a wheelchair and has consulted 27 doctors without definitive diagnosis. His insurer, Kaiser Permanente, cut short his inpatient rehabilitation stay and ended home therapy after two-and-a-half weeks, determining they had “done all we can for you.” Klint bought his own wheelchair and walker for $1,000 while watching his investment portfolio dwindle.
Virginia resident Angel M. pays $400-$600 monthly for physical therapy and dry needling after Anthem Blue Cross Blue Shield deemed occipital nerve blocks and surgery “experimental.” Despite a PPO plan costing her family nearly $20,000 annually, her insurer covers none of her ongoing pain management.
The fundamental obstacle lies in diagnostic coding. The International Classification of Diseases system dictates insurance reimbursement, yet the United States lacks specific codes for COVID-19 vaccine injury syndromes. The CDC currently categorizes these cases under generic codes such as T50.B95A (adverse effect of other viral vaccines) or T88.1 (other complications following immunization) — categories that trigger automatic denial for specialized treatments.
Germany implemented WHO emergency code U12.9 in March 2021, enabling researchers to track 28,287 adverse reactions across 908,869 vaccinations with precision. A study in the International Journal of Environmental Research and Public Health demonstrated how this coding allowed epidemiological analysis and evidence-based treatment protocols United States healthcare providers cannot replicate.
React19, an organization supporting patients with post-vaccination symptoms, submitted a formal proposal to the CDC’s National Center for Health Statistics requesting creation of a Uxx code block for Post-COVID Vaccine Syndrome including system-specific subcategories for neurological, cardiovascular and autoimmune manifestations. The CDC’s ICD-10 Coordination and Maintenance Committee placed the petition on its agenda, with advocates urging discussion in October 2025 rather than March 2026 due to urgent patient needs.
The financial toll compounds medical suffering. Baker, who lost her job and insurance coverage, now carries a high-deductible plan requiring $15,000 out-of-pocket before coverage begins. Her switch to Medicare with United Healthcare supplemental coverage in 2026 resulted in denied IVIG requests without explanation, forcing her into emergency rooms every six weeks for partial treatment.
“If I was mandated to get an experimental shot to keep my job, shouldn’t we be able to try experimental treatments to try and heal us?” Smith asked.
Angel M. estimates her family spends $30,000 annually on healthcare costs, including treatments her insurer refuses to cover despite her inability to return to work.
The Centers for Medicare & Medicaid Services introduced a new medical code for diagnosing and treating vaccine injuries this month, set to take effect Jan. 1, 2027. The code will be available to Medicaid physicians and private insurers, though adoption remains uncertain. The Defender contacted 24 major private insurers about coverage policies but received no responses by press time.
The pattern of systematic denial reveals a healthcare system structurally unprepared for the consequences of its own vaccination mandates. When patients are coerced into receiving experimental medical products to maintain employment — and then denied coverage for resulting injuries — the question shifts from individual misfortune to systemic failure. The irony remains stark: mandated experimental vaccines, by insurers' own logic, should logically warrant access to similarly experimental treatments for resulting harm. Until specific ICD-10 codes allow proper documentation and reimbursement, thousands of vaccine-injured Americans will continue paying the price — in dollars, health and dignity.
Sources for this article include: